Skip to main content

and
  1. No Access

    Chapter

    Trends in Dupuytren Treatment in the United States

    Introduction: The Federal Drug Administration (FDA) approved the use of collagenase clostridium histolyticum (CCH) in the United States in February 2010. This study addresses the impact of that approval on the d...

    Scott Hadley, Emerson Floyd, John Zhao in Dupuytren Disease and Related Diseases - T… (2017)